Prostaglandin E2 Via Steroidogenic Factor-1 Coordinately Regulates Transcription of Steroidogenic Genes Necessary for Estrogen Synthesis in Endometriosis

Overview

Journal J Clin Endocrinol Metab

Publisher Oxford University Press

Specialty Endocrinology

Date 2008 Nov 13

PMID 19001523

Citations 80

Authors

Erkut Attar

Hideki Tokunaga

Gonca Imir

M Bertan Yilmaz

David Redwine

Michael Putman

Bilgin Gurates

Rukset Attar

Nobuo Yaegashi

Dale B Hales

Serdar E Bulun

Affiliations

Soon will be listed here.

Abstract

Context: Products of at least five specific steroidogenic genes, including steroidogenic acute regulatory protein (StAR), which facilitates the entry of cytosolic cholesterol into the mitochondrion, side chain cleavage P450 enzyme, 3beta-hydroxysteroid-dehydrogenase-2, 17-hydroxylase/17-20-lyase, and aromatase, which catalyzes the final step, are necessary for the conversion of cholesterol to estrogen. Expression and biological activity of StAR and aromatase were previously demonstrated in endometriosis but not in normal endometrium. Prostaglandin E2 (PGE2) induces aromatase expression via the transcriptional factor steroidogenic factor-1 (SF1) in endometriosis, which is opposed by chicken-ovalbumin upstream-transcription factor (COUP-TF) and Wilms' tumor-1 (WT1) in endometrium.

Objective: The aim of the study was to demonstrate a complete steroidogenic pathway leading to estrogen biosynthesis in endometriotic cells and the transcriptional mechanisms that regulate basal and PGE2-stimulated estrogen production in endometriotic cells and endometrium.

Results: Compared with normal endometrial tissues, mRNA levels of StAR, side chain cleavage P450, 3beta-hydroxysteroid-dehydrogenase-2, 17-hydroxylase/17-20-lyase, aromatase, and SF1 were significantly higher in endometriotic tissues. PGE2 induced the expression of all steroidogenic genes; production of progesterone, estrone, and estradiol; and StAR promoter activity in endometriotic cells. Overexpression of SF1 induced, whereas COUP-TFII or WT1 suppressed, StAR promoter activity. PGE2 induced coordinate binding of SF1 to StAR and aromatase promoters but decreased COUP-TFII binding in endometriotic cells. COUP-TFII or WT1 binding to both promoters was significantly higher in endometrial compared with endometriotic cells.

Conclusion: Endometriotic cells contain the full complement of steroidogenic genes for de novo synthesis of estradiol from cholesterol, which is stimulated by PGE2 via enhanced binding of SF1 to promoters of StAR and aromatase genes in a synchronous fashion.

Citing Articles

Perturbations of the endometrial immune microenvironment in endometriosis and adenomyosis: their impact on reproduction and pregnancy.

Shi J, Xu Q, Yu S, Zhang T Semin Immunopathol. 2025; 47(1):16.

PMID: 39966111 PMC: 11835911. DOI: 10.1007/s00281-025-01040-1.

Spatial transcriptomic analysis identifies epithelium-macrophage crosstalk in endometriotic lesions.

Burns G, Fu Z, Vegter E, Madaj Z, Greaves E, Flores I iScience. 2025; 28(2):111790.

PMID: 39935459 PMC: 11810701. DOI: 10.1016/j.isci.2025.111790.

The Estrogen-Immune Interface in Endometriosis.

Greygoose E, Metharom P, Kula H, Seckin T, Seckin T, Ayhan A Cells. 2025; 14(1.

PMID: 39791759 PMC: 11720315. DOI: 10.3390/cells14010058.

Progressively Diminished Prostaglandin E2 Signaling in Concordance with Increasing Fibrosis in Ectopic Endometrium.

Yi Y, Nie J, Liu X, Guo S Reprod Sci. 2024; .

PMID: 39174854 DOI: 10.1007/s43032-024-01658-w.

[Research Progress in the Role of Mitochondrial Dysfunction in Endometriosis-Associated Infertility].

Gong X, Huang J, Wang C Sichuan Da Xue Xue Bao Yi Xue Ban. 2024; 55(3):521-526.

PMID: 38948278 PMC: 11211786. DOI: 10.12182/20240560404.

References

Nachtigal M, Hirokawa Y, Flanagan J, Hammer G, Ingraham H . Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell. 1998; 93(3):445-54. DOI: 10.1016/s0092-8674(00)81172-1. View

Deb S, Zhou J, Jianfeng Z, Amin S, Imir A, Gonca I . A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts. J Biol Chem. 2005; 281(5):2585-97. DOI: 10.1074/jbc.M508498200. View

Manna P, Dyson M, Eubank D, Clark B, Lalli E, Sassone-Corsi P . Regulation of steroidogenesis and the steroidogenic acute regulatory protein by a member of the cAMP response-element binding protein family. Mol Endocrinol. 2002; 16(1):184-99. DOI: 10.1210/mend.16.1.0759. View

Wright J, Akhtar M, Akhtar M . Modulation of the activity of human 17 alpha-hydroxylase-17,20-lyase (CYP17) by cytochrome b5: endocrinological and mechanistic implications. Biochem J. 1995; 308 ( Pt 3):901-8. PMC: 1136809. DOI: 10.1042/bj3080901. View

Christenson L, Strauss 3rd J . Steroidogenic acute regulatory protein: an update on its regulation and mechanism of action. Arch Med Res. 2001; 32(6):576-86. DOI: 10.1016/s0188-4409(01)00338-1. View

Toaff M, Schleyer H, Strauss 3rd J . Metabolism of 25-hydroxycholesterol by rat luteal mitochondria and dispersed cells. Endocrinology. 1982; 111(6):1785-90. DOI: 10.1210/endo-111-6-1785. View

Miller W, Strauss 3rd J . Molecular pathology and mechanism of action of the steroidogenic acute regulatory protein, StAR. J Steroid Biochem Mol Biol. 1999; 69(1-6):131-41. DOI: 10.1016/s0960-0760(98)00153-8. View

Ryan I, Taylor R . Endometriosis and infertility: new concepts. Obstet Gynecol Surv. 1997; 52(6):365-71. DOI: 10.1097/00006254-199706000-00021. View

Attar E, Bulun S . Aromatase and other steroidogenic genes in endometriosis: translational aspects. Hum Reprod Update. 2005; 12(1):49-56. DOI: 10.1093/humupd/dmi034. View

10.

Auchus R, Lee T, Miller W . Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer. J Biol Chem. 1998; 273(6):3158-65. DOI: 10.1074/jbc.273.6.3158. View

11.

Attar E, Bulun S . Aromatase inhibitors: the next generation of therapeutics for endometriosis?. Fertil Steril. 2006; 85(5):1307-18. DOI: 10.1016/j.fertnstert.2005.09.064. View

12.

Utsunomiya H, Cheng Y, Lin Z, Reierstad S, Yin P, Attar E . Upstream stimulatory factor-2 regulates steroidogenic factor-1 expression in endometriosis. Mol Endocrinol. 2008; 22(4):904-14. PMC: 2276471. DOI: 10.1210/me.2006-0302. View

13.

Sun H, Hsiao K, Hsu C, Wu M, Tsai S . Transactivation of steroidogenic acute regulatory protein in human endometriotic stromalcells is mediated by the prostaglandin EP2 receptor. Endocrinology. 2003; 144(9):3934-42. DOI: 10.1210/en.2003-0289. View

14.

Bulun S, Cheng Y, Yin P, Imir G, Utsunomiya H, Attar E . Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol. 2006; 248(1-2):94-103. DOI: 10.1016/j.mce.2005.11.041. View

15.

Giudice L, Kao L . Endometriosis. Lancet. 2004; 364(9447):1789-99. DOI: 10.1016/S0140-6736(04)17403-5. View

16.

Noble L, Simpson E, Johns A, Bulun S . Aromatase expression in endometriosis. J Clin Endocrinol Metab. 1996; 81(1):174-9. DOI: 10.1210/jcem.81.1.8550748. View

17.

Manna P, Eubank D, Lalli E, Sassone-Corsi P, Stocco D . Transcriptional regulation of the mouse steroidogenic acute regulatory protein gene by the cAMP response-element binding protein and steroidogenic factor 1. J Mol Endocrinol. 2003; 30(3):381-97. DOI: 10.1677/jme.0.0300381. View

18.

Zeitoun K, Takayama K, Michael M, Bulun S . Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same.... Mol Endocrinol. 1999; 13(2):239-53. DOI: 10.1210/mend.13.2.0229. View

19.

Gurates B, Sebastian S, Yang S, Zhou J, Tamura M, Fang Z . WT1 and DAX-1 inhibit aromatase P450 expression in human endometrial and endometriotic stromal cells. J Clin Endocrinol Metab. 2002; 87(9):4369-77. DOI: 10.1210/jc.2002-020522. View

20.

Ryan I, Schriock E, Taylor R . Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro. J Clin Endocrinol Metab. 1994; 78(3):642-9. DOI: 10.1210/jcem.78.3.8126136. View